Brokerages Set ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Price Target at $26.83
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fourteen analysts that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average […]
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fourteen analysts that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average […]
